GlassScriptPhysician profile
Delbert L Mccaig
NPI 1134189632
$2,177.41
in general payments reported to CMS, 2019-2025
37 companies · $557 in 2025
The $557 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $146 · 2021: $301 · 2022: $419 · 2023: $314 · 2024: $174 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028 · Entertainment: $15.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.45 |
| Entertainment | $15.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $228.73 | 2023-2025 | Gemtesa |
| Novo Nordisk INC | $223.41 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $207.59 | 2025 | Korlym |
| Abbvie INC. | $156.74 | 2021-2023 | |
| Sunovion Pharmaceuticals INC. | $155.21 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $127.71 | 2022-2023 | |
| Astellas Pharma US INC | $89.80 | 2019-2023 | Veozah |
| Glaxosmithkline, LLC. | $77.24 | 2021-2023 | Trelegy Ellipta |
| Stryker Corporation | $64.07 | 2021 | |
| Novartis Pharmaceuticals Corporation | $62.71 | 2019-2023 | |
| Xeris Pharmaceuticals, INC. | $61.46 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $59.86 | 2019-2022 | |
| Dexcom, INC. | $59.52 | 2021-2023 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $55.04 | 2022-2024 | Farxiga |
| Lilly USA, LLC | $50.04 | 2022-2023 | Mounjaro |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Delbert Mccaig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.